Cancer Research

How Does COOKIE-Pro Revolutionize Safer Drug Design?
Research & Development How Does COOKIE-Pro Revolutionize Safer Drug Design?

In the ever-evolving field of pharmaceutical development, the quest for safer and more effective drugs remains a critical challenge, especially when it comes to covalent inhibitors—a class of drugs known for their potent action but also their potential for harmful side effects. A groundbreaking

Digital Tools Boost Genetic Counseling for Young Cancer Survivors
Research & Development Digital Tools Boost Genetic Counseling for Young Cancer Survivors

I'm thrilled to sit down with Ivan Kairatov, a biopharma expert with a wealth of knowledge in technology and innovation within the industry. With his extensive background in research and development, Ivan offers unique insights into the groundbreaking AYA ACCESS study, which explores how digital

Two Decades of NK Cell Therapy for AML: Progress and Challenges
Research & Development Two Decades of NK Cell Therapy for AML: Progress and Challenges

For over 20 years, the medical community has been exploring innovative ways to combat acute myeloid leukemia (AML), a devastating blood cancer notorious for its aggressive progression and high relapse rates despite treatments like chemotherapy and stem cell transplantation. Among the most promising

How Will AI Transform Pediatric Cancer Research Funding?
Research & Development How Will AI Transform Pediatric Cancer Research Funding?

The battle against pediatric cancer remains one of the most emotionally charged and urgent challenges in modern healthcare, impacting thousands of young lives across the United States each year with diagnoses that shatter families and communities. Despite progress in medical science, many children

Ozempic and Mounjaro Surge to Top Three in H1 2025 Pharma
Research & Development Ozempic and Mounjaro Surge to Top Three in H1 2025 Pharma

In the fast-evolving world of pharmaceuticals, the first half of this year has delivered a stunning reshuffle in the hierarchy of blockbuster drugs, with Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro vaulting into the top three revenue earners. This dramatic rise, fueled by an insatiable demand

Boosting Immunity to Prevent Cancer Recurrence and Survival
Research & Development Boosting Immunity to Prevent Cancer Recurrence and Survival

In a world where cancer remains one of the most formidable health challenges, groundbreaking research is shedding light on innovative ways to harness the body’s own defenses to combat this disease and improve patient outcomes. Recent studies have unveiled a promising strategy that focuses on

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later